Vitamin C twice a day enhances health
Alfred Roc Ordman
DOI: 10.4236/health.2010.28123   PDF   HTML     6,475 Downloads   18,511 Views   Citations


This review provides information determining how much vitamin C to take, including analysis of the recent findings, which demonstrate advantages and problems with higher daily doses. The Daily Value for vitamin C was raised to 90 mg for men in 2000, and Upper Limit of 2,000 mg per day was established as being safe. This followed a study of urinary excretion of vitamin C (AA) that demonstrated 500 mg twice a day provides levels sufficient to cause continuous urinary excretion in humans. That is the lowest oral dosage evaluated that significantly saturates blood plasma. A later study endorsed 200 mg from dietary sources for the RDA. Even though plasma concentration of AA is then significantly lower, at 200 mg daily certain white blood cells are saturated with AA. Recently many studies have indicated the benefit of high levels of AA to maintain the brain, bones, and heart, reduce damage from stroke, brain trauma, and cataracts, and lower the risk of cancer metastasis and colds. Pro-oxidant activity has been found only for i.v. adminstration, where high concentrations appear effective destroying tumor cells while not harming normal cells. This review evaluates recent research and finds it consistent with the hypothesis that people, especially older people and soldiers in combat environments, are likely to benefit if they maintain the saturating level of AA by taking 500mg supplements twice a day.

Share and Cite:

Ordman, A. (2010) Vitamin C twice a day enhances health. Health, 2, 819-823. doi: 10.4236/health.2010.28123.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Beckman, K.B. and Ames, B.N. (1998b) The free radical theory of aging matures. Physiological Reviews, 78(2), 547-581.
[2] Pauling, L. (1970) Vitamin C the common cold. W. H. Freeman, San Francisco.
[3] King, G., Beins, M., Larkin, J., Summers, B. and Ordman, A.B. (1994) Rate of excretion of vitamin C in human urine. AGE, 17(1), 87-92.
[4] Levine, M., Conry-Cantilena, C., Wang, Y., Welch, R.W. and Cantilena, L.R. (1996) Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences of the United States of America, 93(8), 3704- 3709.
[5] Podmore, I.D., Griffiths, H.R., Herbert, K.E., Mistry, N., Mistry, P. and Lunec, J. (1998) Vitamin C exhibits pro- oxidant properties. Nature, 392(6676), 559.
[6] Frei, B. and Lawson, S. (2008) Vitamin C and cancer revisited. Proceedings of the National Academy of Sciences of the United States of America, 105(32), 11037- 11038.
[7] Helbock, H.J., Beckman, K.B., Shigenaga, M.K., Walter, P., Woodall, A.A., Yeo, H.C. and Ames, B.N. (1998) DNA oxidation matters: The HPLC-EC assay of 8-oxo- deoxyguanosine and 8-oxo-guanine. Proceedings of the National Academy of Sciences of the United States of America, 95(1), 288-293.
[8] Park, E.M., Shigenaga, M.K., Degan, P., Korn, T.S., Kitzler, J.W., Wehr, C.M., Kolachana, P. and Ames, B.N. (1992) Assay of excised oxidative DNA lesions: Isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proceedings of the National Academy of Sciences of the United States of America, 89(8), 3375-3379.
[9] Food and Nutrition Board (2000) Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. National Academy of Sciences.
[10] Naidu, K.A. (2003) Vitamin C in human health and disease is still a mystery? An overview. Journal of Nutrition, 2(7), 7-23.
[11] Hathcock, J.N., Azzi, A., Blumberg, J., Bray, T., Dickinson, A., Frei, B., Jialal, I., Johnston, C.S., Kelly, F.J., Kraemer, K., Packer, L., Parthasarathy, S., Sies, H., Traber, M.J. (2005) Vitamins E and C are safe across a broad range of intakes. American Journal of Clinical Nutrition, 81(4), 736-745.
[12] Bhalla, U.S. and Iyengar, R. (1999) Emergent properties of networks of biological signaling pathways. Science, 283(5400), 381-387.
[13] Ordman, A.B. (2008) Pilot study for an age and gender-based nutrient signaling system for weight control. AGE, 30(2), 201-208.
[14] Zwei?er, R.M. (2003) Management of acute stroke. Southern Medical Journal, 96(4), 380-385.
[15] Su, H., Gornitsky, M., Geng, G., Velly, A.M., Chertkow, H. and Schipper, H.M. (2008) Diurnal variations in salivary protein carbonyl levels in normal and cognitively impaired human subjects. AGE, 30(1), 1-9.
[16] Araujo, J.A., Studzinski, C.M., Head, E., Cotman, C.W. and Milgram, N.W. (2005) Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging. AGE, 27(1), 27-37.
[17] Frank, B. and Gupta, S. (2005) A review of antioxidants and Alzheimer’s disease. Annals of Clinical Psychiatry, 17(4), 269-286.
[18] T?ien, O., Drew, K.L., Chao, M.L. and Rice, M.E. (2001) Ascorbate dynamics and oxygen consumption during arousal from hibernation in Arctic ground squirrels. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 281(2), R572-R583.
[19] Rozell, N. (1998) Of ground squirrels, Vitamin C and stroke. Alaska Science Forum Article, #1378.
[20] Polidori, M.C., Mecocci, P. and Frei, B. (2001) Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke, 32(4), 898-902.
[21] Polidori, M.C., Pratic, D., Ingegni, T., Mariani, E., Spazzafumo, L., Del Sindaco, P., Cecchetti, R., Yao, Y., Ricci, S., Cherubini, A., Stahl, W., Sies, H., Senin, U. and Mecocci, P. (2005) Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: Results of the AVASAS Study. BioFactors, 24(1-4), 265-274.
[22] Adler, E.M. (2008) Science signaling: Sirtuin to become astrocytes. Science, 320(5874), 291.
[23] Prozorovski, T., Schulze-Topphoff, U., Glumm, R., Baumgart, J., Schr?ter, F., Ninnemann, O., Siegert, E., Bendix, I., Brüstle, O., Nitsch, R., Zipp, F. and Aktas, O. (2008) Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nature Cell Biology, 10(4), 385-394.
[24] Song, H., Kempermann, G., Wadiche, L. O., Zhao, C., Schinder, A.F., Bischofberger, J. (2005) New neurons in the adult mammalian brain: Synaptogenesis and functional integration. The Journal of Neuroscience, 25(45), 10366-10368.
[25] Levine, G.N., Frei, B., Koulouris, S.N., Gerhard, M.D., Keaney, J.F. and Vita, J.A. (1996) Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation, 93(87), 1107-1113.
[26] Takahashi, T., Lord, B., Schulze, P.C., Fryer, R.M., Sarang, S.S., Gullans, S.R. and Lee, R.T. (2003) Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation, 107(3), 1912-1916.
[27] Johnston, C.S. and Cox, S.K. (2001) Plasma-saturating intakes of vitamin C confer maximal antioxidant protection to plasma. American Journal of Clinical Nutrition, 20(6), 623-627.
[28] Beutler, E., Lichtman, M.A., Coller, B.S. and Kipp, T.J. (1995) Williams hematology. 5th Edition, McGraw-Hill, New York, L26.
[29] Moser, L.R. and Ordman, A.B. (2006) Design for a study to determine optimal dosage of ascorbic acid and alpha- tocopherol in humans. AGE, 28(1), 77-84.
[30] Valero, M.P., Fletcher, A.E., De Stavola, B.L., Vioque, J. and Alepuz, V.C. (2002) Vitamin C is associated with reduced risk of cataract in a Mediterranean population. Journal of Nutrition, 132(6), 1299-1306.
[31] Sahni, S., Hannan, M.T., Gagnon, D., Blumberg, J., Cupples, L.A., Kiel, D.P. and Tucker, K.L. (2008) High vitamin C intake is associated with lower 4-year bone loss in elderly men. Journal of Nutrition, 138(10), 1931-1938.
[32] Hemil?, H. (1996) Vitamin C supplementation and common cold symptoms: Problems with inaccurate reviews. Nutrition, 12(11), 804-809.
[33] Douglas, R.M. and Hemil?, H. (2005) Vitamin C for preventing and treating the common cold. PLoS Medicine, 2(6), e168.
[34] Sasazuki, S., Sasaki, S., Tsubono, Y., Okubo, S., Hayashi, M. and Tsugane, S. (2006) Effect of vitamin C on common cold: Randomized controlled trial. European Journal of Clinical Nutrition, 60(1), 9-17.
[35] Beckman, K.B. and Ames, B.N. (1998a) Mitochondrial aging: Open questions. Annals of the New York Academy of Sciences, 854, 118-127.
[36] Gredilla, R., Sanz, A., Lopez-Torres, M. and Barja, G. (2001) Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart. The Federation of American Societies for Experimental Biology Journal, 15(9), 1589-1591.
[37] Myers, M.W. and Bosmann, H.B. (1974) Mitochondria! Protein content and enzyme activity of reuber hepatoma H-351. Cancer Research, 34(8), 1989-1994.
[38] Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y. and Hayashi, J. (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science, 320(5876), 661-664.
[39] Sakagami, H., Satoh, K., Hakeda, Y. and Kumegawa, M. (2000) Apoptosis-inducing activity of vitamin C and vitamin K. Cell and Molecular Biology, 46(1), 129-143.
[40] Chen, Q., Espey, M.G., Sun, A.Y., Pooput, C., Kirk, K.L., Krishna, M.C., Khosh, D.B., Drisko, J. and Levine, M. (2008) Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts. Proceedings of the National Academy of Sciences of the United States of America, 105(32), 11037-11038.
[41] Padayatty, S.J., Sun, H., Wang, Y., Riordan, H.D., Hewitt, S.M., Katz, A., Wesley, R.A. and Levine, M. (2004) Vitamin C pharmacokinetics: Implications for oral and intravenous Use. Annals of Internal Medicine, 140(7), 533- 537.
[42] Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R. G. and Gluud, C. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. Journal of the American Medical Association, 297(8), 842-857.
[43] Ordman, A.B. (1999) Background for a consensus on the value of consuming vitamin C and E supplements. AGE, 22(1), 127.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.